JP2014530226A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530226A5 JP2014530226A5 JP2014535044A JP2014535044A JP2014530226A5 JP 2014530226 A5 JP2014530226 A5 JP 2014530226A5 JP 2014535044 A JP2014535044 A JP 2014535044A JP 2014535044 A JP2014535044 A JP 2014535044A JP 2014530226 A5 JP2014530226 A5 JP 2014530226A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- subject
- antibody
- tnf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161545864P | 2011-10-11 | 2011-10-11 | |
| US61/545,864 | 2011-10-11 | ||
| EP12305889 | 2012-07-20 | ||
| EP12305889.3 | 2012-07-20 | ||
| PCT/EP2012/070052 WO2013053751A1 (en) | 2011-10-11 | 2012-10-10 | Compositions for the treatment of rheumatoid arthritis and methods of using same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017064130A Division JP6336171B2 (ja) | 2011-10-11 | 2017-03-29 | 関節リウマチを治療するための組成物およびこれを用いる方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014530226A JP2014530226A (ja) | 2014-11-17 |
| JP2014530226A5 true JP2014530226A5 (enExample) | 2015-12-03 |
| JP6122018B2 JP6122018B2 (ja) | 2017-04-26 |
Family
ID=48081395
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014535044A Active JP6122018B2 (ja) | 2011-10-11 | 2012-10-10 | 関節リウマチを治療するための組成物およびこれを用いる方法 |
| JP2017064130A Active JP6336171B2 (ja) | 2011-10-11 | 2017-03-29 | 関節リウマチを治療するための組成物およびこれを用いる方法 |
| JP2018086193A Active JP6983717B2 (ja) | 2011-10-11 | 2018-04-27 | 関節リウマチを治療するための組成物およびこれを用いる方法 |
| JP2020088567A Active JP7025477B2 (ja) | 2011-10-11 | 2020-05-21 | 関節リウマチを治療するための組成物およびこれを用いる方法 |
| JP2024039618A Pending JP2024069453A (ja) | 2011-10-11 | 2024-03-14 | 関節リウマチを治療するための組成物およびこれを用いる方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017064130A Active JP6336171B2 (ja) | 2011-10-11 | 2017-03-29 | 関節リウマチを治療するための組成物およびこれを用いる方法 |
| JP2018086193A Active JP6983717B2 (ja) | 2011-10-11 | 2018-04-27 | 関節リウマチを治療するための組成物およびこれを用いる方法 |
| JP2020088567A Active JP7025477B2 (ja) | 2011-10-11 | 2020-05-21 | 関節リウマチを治療するための組成物およびこれを用いる方法 |
| JP2024039618A Pending JP2024069453A (ja) | 2011-10-11 | 2024-03-14 | 関節リウマチを治療するための組成物およびこれを用いる方法 |
Country Status (31)
| Country | Link |
|---|---|
| US (3) | US10927435B2 (enExample) |
| EP (1) | EP2766039B1 (enExample) |
| JP (5) | JP6122018B2 (enExample) |
| KR (3) | KR20140123474A (enExample) |
| CN (2) | CN108310376A (enExample) |
| AR (1) | AR088289A1 (enExample) |
| AU (1) | AU2012323062B2 (enExample) |
| BR (1) | BR112014008764A8 (enExample) |
| CA (1) | CA2851751A1 (enExample) |
| CL (1) | CL2014000926A1 (enExample) |
| CO (1) | CO6950482A2 (enExample) |
| DK (1) | DK2766039T3 (enExample) |
| ES (1) | ES2660112T3 (enExample) |
| HU (1) | HUE036561T2 (enExample) |
| IL (1) | IL232001A0 (enExample) |
| LT (1) | LT2766039T (enExample) |
| MA (1) | MA35620B1 (enExample) |
| MX (3) | MX353126B (enExample) |
| MY (1) | MY177212A (enExample) |
| NO (1) | NO2766039T3 (enExample) |
| PH (1) | PH12014500784B1 (enExample) |
| PL (1) | PL2766039T3 (enExample) |
| PT (1) | PT2766039T (enExample) |
| RS (1) | RS56973B1 (enExample) |
| RU (1) | RU2664697C2 (enExample) |
| SG (3) | SG10201807042YA (enExample) |
| SI (1) | SI2766039T1 (enExample) |
| TR (1) | TR201802387T4 (enExample) |
| TW (1) | TWI589299B (enExample) |
| UY (1) | UY34387A (enExample) |
| WO (1) | WO2013053751A1 (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3672B1 (ar) | 2008-12-15 | 2020-08-27 | Regeneron Pharma | أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9). |
| JO3417B1 (ar) | 2010-01-08 | 2019-10-20 | Regeneron Pharma | الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r |
| BR112013018740A2 (pt) | 2011-01-28 | 2019-01-08 | Sanofi Sa | anticorpos humanos para pcsk9 para uso em métodos de tratamento de grupos específicos de indivíduos |
| AR087305A1 (es) | 2011-07-28 | 2014-03-12 | Regeneron Pharma | Formulaciones estabilizadas que contienen anticuerpos anti-pcsk9, metodo de preparacion y kit |
| TWI589299B (zh) * | 2011-10-11 | 2017-07-01 | 再生元醫藥公司 | 用於治療類風濕性關節炎之組成物及其使用方法 |
| US9943594B2 (en) | 2011-10-11 | 2018-04-17 | Sanofi Biotechnology | Methods for the treatment of rheumatoid arthritis |
| CA2899746A1 (en) * | 2013-01-31 | 2014-06-26 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Pharmaceutical composition comprising leflunomide |
| CN105765386B (zh) | 2013-10-31 | 2019-07-16 | 瑞泽恩制药公司 | 用于检测中和抗体的竞争性配体结合测定法 |
| ES2799439T3 (es) * | 2013-11-22 | 2020-12-17 | Sanofi Biotechnology | Composiciones para el tratamiento de la artritis reumatoide y métodos de uso de las mismas |
| WO2015077582A1 (en) * | 2013-11-22 | 2015-05-28 | Sanofi Biotechnology | Compositions for the treatment of rheumatoid arthritis and methods of using same |
| PT3193934T (pt) * | 2014-09-16 | 2021-10-19 | Regeneron Pharma | Composições para melhoria da qualidade de vida relacionada com a saúde de pacientes com artrite reumatoide |
| AR102198A1 (es) | 2014-10-09 | 2017-02-08 | Regeneron Pharma | Proceso para reducir partículas subvisibles en una formulación farmacéutica |
| JP2018523684A (ja) | 2015-08-18 | 2018-08-23 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | リポタンパク質アフェレーシスを受けている高脂血症の患者を治療するための抗ｐｃｓｋ９阻害抗体 |
| EP3371224A1 (en) * | 2015-11-03 | 2018-09-12 | Sanofi Biotechnology | Compositions comprising il6r antibodies for the treatment of uveitis and macular edema and methods of using same |
| KR101895950B1 (ko) * | 2015-12-18 | 2018-09-06 | (주)한국비엠아이 | 골관절염 치료를 위한 친수화된 설파살라진 및 히알루론산을 포함하는 조성물 및 이의제조방법 |
| TWI819435B (zh) * | 2016-03-07 | 2023-10-21 | 法商賽諾菲生物技術公司 | 用於治療類風濕性關節炎之組成物及方法 |
| EP3216461A1 (en) * | 2016-03-07 | 2017-09-13 | Sanofi Biotechnology | Compositions and methods for treating rheumatoid arthritis |
| CN107456455B (zh) * | 2016-06-06 | 2021-09-24 | 海南先声药业有限公司 | 一种预防或治疗炎性疾病的药物组合物 |
| MX2019000935A (es) | 2016-08-16 | 2019-07-04 | Regeneron Pharma | Metodos para cuantificar anticuerpos individuales de una mezcla. |
| IL312194B1 (en) | 2016-10-25 | 2026-01-01 | Regeneron Pharma | Methods and systems for analyzing chromatography data |
| MX2020002850A (es) | 2017-09-19 | 2020-07-24 | Regeneron Pharma | Metodos para reducir la formacion de particulas y composiciones formadas a partir de estas. |
| WO2019118187A1 (en) * | 2017-12-13 | 2019-06-20 | Regeneron Pharmaceuticals, Inc. | Devices and systems for chromatography column bed support management and related methods |
| WO2019136221A1 (en) * | 2018-01-05 | 2019-07-11 | Attillaps Holdings | Treating autoimmune disorders with chloroquine and/or hydroxychloroquine |
| CN108597083A (zh) * | 2018-04-28 | 2018-09-28 | 江苏食品药品职业技术学院 | 一种酒店旅游自助服务系统 |
| TWI903214B (zh) | 2018-05-02 | 2025-11-01 | 美商里珍納龍藥品有限公司 | 用於評估生化過濾器的適合性的方法 |
| MA52966A (fr) * | 2018-06-19 | 2021-04-28 | Regeneron Pharma | Anticorps anti-facteur xii/xiia et leurs utilisations |
| TWI853823B (zh) | 2018-07-02 | 2024-09-01 | 美商里珍納龍藥品有限公司 | 自混合物製備多肽之系統及方法 |
| CN109013990A (zh) * | 2018-08-04 | 2018-12-18 | 安徽盛美金属科技有限公司 | 一种加热铝合金锻压件坯料的装置 |
| CN112955222A (zh) | 2018-08-29 | 2021-06-11 | 里珍纳龙药品有限公司 | 用于治疗患有类风湿性关节炎的个体的方法和组合物 |
| CN109858649A (zh) * | 2019-01-04 | 2019-06-07 | 珠海格力电器股份有限公司 | 预订酒店方法和装置、酒店管理方法和装置 |
| TW202521583A (zh) | 2019-01-31 | 2025-06-01 | 法商賽諾菲生物技術公司 | 用於治療幼年原發性關節炎之組成物及方法 |
| MA55760A (fr) | 2019-04-24 | 2022-03-02 | Regeneron Pharma | Procédés de diagnostic et de traitement de la polyarthrite rhumatoïde |
| JP2022534794A (ja) | 2019-06-04 | 2022-08-03 | サノフィ・バイオテクノロジー | 関節リウマチを有する対象における疼痛を治療するための組成物および方法 |
| KR102453140B1 (ko) | 2021-09-07 | 2022-10-11 | 배호진 | 블록체인을 이용한 후원자 보상 방법 및 장치 |
| WO2026047197A1 (en) * | 2024-08-30 | 2026-03-05 | Sanofi Biotechnology | Differential biomarkers for anti-interleukin-6 and anti-tumor necrosis factor-α treatment response in rheumatoid arthritis |
Family Cites Families (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0747045B2 (ja) | 1986-10-15 | 1995-05-24 | 株式会社大協精工 | 積層した注射器用滑栓 |
| US5171840A (en) | 1988-01-22 | 1992-12-15 | Tadamitsu Kishimoto | Receptor protein for human B cell stimulatory factor-2 |
| US5670373A (en) | 1988-01-22 | 1997-09-23 | Kishimoto; Tadamitsu | Antibody to human interleukin-6 receptor |
| US5216128A (en) | 1989-06-01 | 1993-06-01 | Yeda Research And Development Co., Ltd. | IFN-β2/IL-6 receptor its preparation and pharmaceutical compositions containing it |
| EP0409607B1 (en) | 1989-07-20 | 1996-10-30 | Tadamitsu Kishimoto | Antibody to human interleukin-6 receptor |
| US5605690A (en) | 1989-09-05 | 1997-02-25 | Immunex Corporation | Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| US5016784A (en) | 1990-02-15 | 1991-05-21 | Dexus Research Inc. | Applicator for highly reactive materials |
| EP1097945B1 (en) | 1991-03-18 | 2007-07-04 | New York University | Monoclonal and chimeric antibody specific for human tumor necrosis factor |
| ES2134212T3 (es) | 1991-04-25 | 1999-10-01 | Chugai Pharmaceutical Co Ltd | Anticuerpo humano reconstituido contra el receptor de la interleuquina 6 humano. |
| JP3100727B2 (ja) | 1992-01-23 | 2000-10-23 | 株式会社大協精工 | 変性ポリシロキサン組成物及び該組成物を被覆した衛生ゴム製品 |
| FR2694767B1 (fr) | 1992-08-13 | 1994-10-21 | Innotherapie Lab Sa | Anticorps monoclonaux anti-IL6R, et leurs applications. |
| JPH07504203A (ja) | 1992-09-15 | 1995-05-11 | イミュネックス・コーポレーション | 腫瘍壊死因子アンタゴニストを用いるｔｎｆ−依存性炎症の治療方法 |
| EP0672144A1 (en) | 1992-10-20 | 1995-09-20 | Chiron Corporation | Interleukin-6 receptor antagonists |
| US5888511A (en) | 1993-02-26 | 1999-03-30 | Advanced Biotherapy Concepts, Inc. | Treatment of autoimmune diseases, including AIDS |
| US5888510A (en) | 1993-07-21 | 1999-03-30 | Chugai Seiyaku Kabushiki Kaisha | Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component |
| WO1995009873A1 (en) | 1993-10-06 | 1995-04-13 | Board Of Regents, The University Of Texas System | A monoclonal anti-human il-6 receptor antibody |
| EP0783893B1 (en) | 1994-10-07 | 2012-04-04 | Chugai Seiyaku Kabushiki Kaisha | Inhibition of abnormal growth of synovial cells using il-6 antagonist as active ingredient |
| WO1996012503A1 (en) | 1994-10-21 | 1996-05-02 | Chugai Seiyaku Kabushiki Kaisha | Remedy for diseases caused by il-6 production |
| JP4079461B2 (ja) | 1994-12-29 | 2008-04-23 | 中外製薬株式会社 | Ｉｌ−６アンタゴニストを含んでなる抗腫瘍剤の作用増強剤 |
| CA2211578C (en) | 1995-02-13 | 2010-09-21 | Chugai Seiyaku Kabushiki Kaisha | Muscle protein proteolysis inhibiting agent containing il-6 receptor antibody |
| JP3172057B2 (ja) | 1995-04-05 | 2001-06-04 | 株式会社大協精工 | ラミネートゴム栓 |
| DE69735888T2 (de) | 1996-06-27 | 2006-11-02 | Chugai Seiyaku K.K. | Mittel gegen myelome, welches zusammen mit antitumorwirkstoffen auf der basis von stickstoffsenfgasen verwendet werden kann |
| US7312196B2 (en) | 1997-01-08 | 2007-12-25 | Amylin Pharmaceuticals, Inc. | Formulations for amylin agonist peptides |
| US20020187150A1 (en) | 1997-08-15 | 2002-12-12 | Chugai Seiyaku Kabushiki Kaisha | Preventive and/or therapeutic agent for systemic lupus erythematosus comprising anti-IL-6 receptor antibody as an active ingredient |
| PT1004315E (pt) | 1997-08-15 | 2008-07-09 | Chugai Pharmaceutical Co Ltd | Profilácticos e/ou medicamentos contendo anticorpos neutralizantes anti-receptor de il-6 para reduzir a excreção de proteínas urinárias no lúpus eritematoso sistémico |
| HU225539B1 (en) | 1998-03-17 | 2007-02-28 | Chugai Pharmaceutical Co Ltd | Preventives or remedies for inflammatory intestinal diseases containing as the active ingredient antibody against il-6 receptor |
| WO2000010607A1 (en) | 1998-08-24 | 2000-03-02 | Chugai Seiyaku Kabushiki Kaisha | Preventives or remedies for pancreatitis containing il-6 antagonists as the active ingredient |
| JP3512349B2 (ja) | 1999-01-29 | 2004-03-29 | 株式会社大協精工 | 柱状ゴム要素の成形型 |
| ATE316531T1 (de) | 1999-10-07 | 2006-02-15 | Lilly Co Eli | Kondensierte dihydrochinolinon-derivate zur hemmung von mrp1 |
| US6659982B2 (en) | 2000-05-08 | 2003-12-09 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
| US6629949B1 (en) | 2000-05-08 | 2003-10-07 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
| US8632778B2 (en) | 2000-08-11 | 2014-01-21 | Chugai Seiyaku Kabushiki Kaisha | Stabilized anti-interleukin-6 antibody-containing preparations |
| US7148197B2 (en) | 2000-08-24 | 2006-12-12 | The Regents Of The University Of California | Orally administered small peptides synergize statin activity |
| EP1327681A4 (en) | 2000-10-20 | 2004-09-01 | Chugai Pharmaceutical Co Ltd | Degraded agonist antibodies |
| AU2002210952B2 (en) | 2000-10-25 | 2007-01-11 | Chugai Seiyaku Kabushiki Kaisha | Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonist |
| JP4889187B2 (ja) | 2000-10-27 | 2012-03-07 | 中外製薬株式会社 | Ｉｌ−６アンタゴニストを有効成分として含有する血中ｍｍｐ−３濃度低下剤 |
| JP2002209975A (ja) | 2001-01-19 | 2002-07-30 | Daikyo Seiko Ltd | 医薬バイアル用ラミネートゴム栓 |
| UA80091C2 (en) | 2001-04-02 | 2007-08-27 | Chugai Pharmaceutical Co Ltd | Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist |
| WO2003009817A2 (en) | 2001-07-25 | 2003-02-06 | Protein Design Labs, Inc. | Stable lyophilized pharmaceutical formulation of igg antibodies |
| ES2436206T3 (es) | 2001-11-14 | 2013-12-27 | Janssen Biotech, Inc. | Anticuerpos anti il-6, composiciones, métodos y usos |
| WO2003068260A1 (fr) | 2002-02-14 | 2003-08-21 | Chugai Seiyaku Kabushiki Kaisha | Produits pharmaceutiques en solution contenant des anticorps |
| US20060078531A1 (en) | 2004-10-12 | 2006-04-13 | Osemwota Sota | Method of prevention and treatment of atherosclerosis, peripheral vascular disease, coronary artery disease, and age-related disorders including osteoporosis, arthritis, type 2 diabetes, dementia and Alzheimer's disease |
| US20060275294A1 (en) | 2002-08-22 | 2006-12-07 | Omoigui Osemwota S | Method of prevention and treatment of aging, age-related disorders and/or age-related manifestations including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimers disease and cancer |
| US20060078532A1 (en) | 2004-10-12 | 2006-04-13 | Omoigui Osemwota S | Method of prevention and treatment of Atherosclerosis, Peripheral vascular disease, Coronary artery disease, aging and age-related disorders including osteoporosis, arthritis, type 2 diabetes, dementia and Alzheimer's disease |
| US20060078533A1 (en) | 2004-10-12 | 2006-04-13 | Omoigui Osemwota S | Method of prevention and treatment of aging and age-related disorders including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimer's disease and cancer |
| US7534427B2 (en) | 2002-12-31 | 2009-05-19 | Immunomedics, Inc. | Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins |
| HRP20050934B1 (hr) | 2003-04-04 | 2014-09-26 | Genentech, Inc. | Formulacije s visokom koncentracijom antitijela i proteina |
| EP2062916A3 (en) | 2003-04-09 | 2009-08-19 | Genentech, Inc. | Therapy of autoimmune disease in a patient with an inadequate response to a TNF-Alpha inhibitor |
| GB2401040A (en) | 2003-04-28 | 2004-11-03 | Chugai Pharmaceutical Co Ltd | Method for treating interleukin-6 related diseases |
| WO2005028514A1 (en) | 2003-09-22 | 2005-03-31 | Biovation Gmbh & Co. Kg. | Use of a compound for reducing the biological effectiveness of il-6 |
| DE10355251A1 (de) | 2003-11-26 | 2005-06-23 | Merck Patent Gmbh | Pharmazeutische Zubereitung enthaltend einen Antikörper gegen den EGF-Rezeptor |
| US8617550B2 (en) | 2003-12-19 | 2013-12-31 | Chugai Seiyaku Kabushiki Kaisha | Treatment of vasculitis with IL-6 antagonist |
| WO2005080429A2 (en) | 2004-02-11 | 2005-09-01 | Warner-Lambert Company Llc | Methods of treating osteoarthritis with anti-il-6 or anti-il6 receptor antibodies |
| EP2399936A3 (en) | 2004-07-26 | 2012-02-22 | Biogen Idec MA Inc. | Anti-CD154 antibodies |
| US20070036788A1 (en) | 2004-09-22 | 2007-02-15 | Ahmed Sheriff | Use of a compound for reducing the biological effectiveness of il-6 |
| WO2006046661A1 (ja) | 2004-10-28 | 2006-05-04 | Osaka University | インターロイキン－６阻害剤 |
| EP1828250A2 (en) | 2004-12-16 | 2007-09-05 | Genentech, Inc. | Methods for treating autoimmune disorders |
| JP2009516692A (ja) | 2005-11-22 | 2009-04-23 | ワイス | 免疫グロブリン融合タンパク質製剤 |
| LT2481753T (lt) | 2005-12-13 | 2018-05-25 | Eli Lilly And Company | Anti-il-17 antikūnai |
| US20080131374A1 (en) | 2006-04-19 | 2008-06-05 | Medich John R | Uses and compositions for treatment of rheumatoid arthritis |
| RS52176B (sr) | 2006-06-02 | 2012-08-31 | Regeneron Pharmaceuticals Inc. | Antitela visokog afiniteta prema humanom il-6 receptoru |
| US8080248B2 (en) * | 2006-06-02 | 2011-12-20 | Regeneron Pharmaceuticals, Inc. | Method of treating rheumatoid arthritis with an IL-6R antibody |
| EP2029163A4 (en) | 2006-06-14 | 2010-08-11 | Imclone Llc | LYOPHILIZED FORMULATIONS OF ANTI-EGFR ANTIBODIES |
| AU2007285695B2 (en) | 2006-08-18 | 2012-05-24 | Ablynx N.V. | Amino acid sequences directed against IL-6R and polypeptides comprising the same for the treatment of diseases and disorders associated with IL-6-mediated signalling |
| WO2008049897A1 (en) | 2006-10-27 | 2008-05-02 | Ablynx N.V. | Intranasal delivery of polypeptides and proteins |
| JP2008189637A (ja) | 2007-02-08 | 2008-08-21 | Snow Brand Milk Prod Co Ltd | 自己免疫疾患予防剤 |
| EP2666787B1 (en) | 2007-05-31 | 2022-02-09 | Genmab A/S | STABLE IgG4 ANTIBODIES |
| WO2009041621A1 (ja) | 2007-09-26 | 2009-04-02 | Chugai Seiyaku Kabushiki Kaisha | 抗il-6レセプター抗体 |
| WO2009095489A2 (en) | 2008-02-01 | 2009-08-06 | Ablynx N.V. | Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling |
| WO2009109584A1 (en) | 2008-03-07 | 2009-09-11 | Ferring International Center S. A. | ANTIBODY BINDING ONLY TO IL6-sIL6R COMPLEX |
| TWI700293B (zh) | 2008-04-11 | 2020-08-01 | 日商中外製藥股份有限公司 | 重複結合複數個抗原的抗體 |
| TWI440469B (zh) | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
| TWI440470B (zh) | 2009-03-19 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | 含改良抗體分子之醫藥配方 |
| JO3030B1 (ar) | 2009-06-26 | 2016-09-05 | Galapagos Nv | مركب جديد مفيد لمعالجة الامراض التنكسية والالتهابات |
| JO3417B1 (ar) * | 2010-01-08 | 2019-10-20 | Regeneron Pharma | الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r |
| US20130053751A1 (en) | 2011-08-31 | 2013-02-28 | Frank Holtham | Needle with an antiseptic swab |
| US9943594B2 (en) | 2011-10-11 | 2018-04-17 | Sanofi Biotechnology | Methods for the treatment of rheumatoid arthritis |
| TWI589299B (zh) | 2011-10-11 | 2017-07-01 | 再生元醫藥公司 | 用於治療類風濕性關節炎之組成物及其使用方法 |
| US20150077582A1 (en) | 2013-09-13 | 2015-03-19 | Texas Instruments Incorporated | Method and system for adapting a device for enhancement of images |
| WO2015077582A1 (en) | 2013-11-22 | 2015-05-28 | Sanofi Biotechnology | Compositions for the treatment of rheumatoid arthritis and methods of using same |
-
2012
- 2012-10-09 TW TW101137198A patent/TWI589299B/zh active
- 2012-10-10 EP EP12769684.7A patent/EP2766039B1/en active Active
- 2012-10-10 AU AU2012323062A patent/AU2012323062B2/en active Active
- 2012-10-10 SG SG10201807042YA patent/SG10201807042YA/en unknown
- 2012-10-10 RU RU2014118741A patent/RU2664697C2/ru active
- 2012-10-10 US US14/350,973 patent/US10927435B2/en active Active
- 2012-10-10 MY MYPI2014001045A patent/MY177212A/en unknown
- 2012-10-10 SG SG11201401373RA patent/SG11201401373RA/en unknown
- 2012-10-10 WO PCT/EP2012/070052 patent/WO2013053751A1/en not_active Ceased
- 2012-10-10 KR KR1020147012534A patent/KR20140123474A/ko not_active Ceased
- 2012-10-10 SI SI201231228T patent/SI2766039T1/en unknown
- 2012-10-10 AR ARP120103770A patent/AR088289A1/es unknown
- 2012-10-10 LT LTEP12769684.7T patent/LT2766039T/lt unknown
- 2012-10-10 NO NO12769684A patent/NO2766039T3/no unknown
- 2012-10-10 RS RS20180191A patent/RS56973B1/sr unknown
- 2012-10-10 TR TR2018/02387T patent/TR201802387T4/tr unknown
- 2012-10-10 BR BR112014008764A patent/BR112014008764A8/pt not_active Application Discontinuation
- 2012-10-10 ES ES12769684.7T patent/ES2660112T3/es active Active
- 2012-10-10 CN CN201810179358.3A patent/CN108310376A/zh active Pending
- 2012-10-10 MX MX2014004398A patent/MX353126B/es active IP Right Grant
- 2012-10-10 DK DK12769684.7T patent/DK2766039T3/en active
- 2012-10-10 JP JP2014535044A patent/JP6122018B2/ja active Active
- 2012-10-10 HU HUE12769684A patent/HUE036561T2/hu unknown
- 2012-10-10 CN CN201280060133.7A patent/CN104105505A/zh active Pending
- 2012-10-10 KR KR1020227007526A patent/KR20220035272A/ko not_active Ceased
- 2012-10-10 KR KR1020197002611A patent/KR20190014117A/ko not_active Ceased
- 2012-10-10 MX MX2017016768A patent/MX388710B/es unknown
- 2012-10-10 PL PL12769684T patent/PL2766039T3/pl unknown
- 2012-10-10 SG SG10201607215SA patent/SG10201607215SA/en unknown
- 2012-10-10 PH PH1/2014/500784A patent/PH12014500784B1/en unknown
- 2012-10-10 PT PT127696847T patent/PT2766039T/pt unknown
- 2012-10-10 CA CA2851751A patent/CA2851751A1/en active Pending
- 2012-10-11 UY UY0001034387A patent/UY34387A/es not_active Application Discontinuation
-
2014
- 2014-04-08 IL IL232001A patent/IL232001A0/en active IP Right Grant
- 2014-04-10 MX MX2021015309A patent/MX2021015309A/es unknown
- 2014-04-11 CL CL2014000926A patent/CL2014000926A1/es unknown
- 2014-05-01 MA MA36969A patent/MA35620B1/fr unknown
- 2014-05-09 CO CO14099490A patent/CO6950482A2/es unknown
-
2017
- 2017-03-29 JP JP2017064130A patent/JP6336171B2/ja active Active
-
2018
- 2018-04-27 JP JP2018086193A patent/JP6983717B2/ja active Active
-
2020
- 2020-05-21 JP JP2020088567A patent/JP7025477B2/ja active Active
- 2020-12-24 US US17/133,870 patent/US20210230719A1/en active Pending
-
2024
- 2024-03-14 JP JP2024039618A patent/JP2024069453A/ja active Pending
-
2025
- 2025-06-30 US US19/254,952 patent/US20260027202A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014530226A5 (enExample) | ||
| RU2014118741A (ru) | Композиции для лечения ревматоидного артрита и способы их применения | |
| JP2024069453A5 (enExample) | ||
| Rudwaleit et al. | Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study | |
| Behrens et al. | MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial | |
| JP2015505564A5 (enExample) | ||
| Perdriger | Infliximab in the treatment of rheumatoid arthritis | |
| HRP20251099T1 (hr) | Učinkovita i djelotvorna kontrola serumskog fosfata za optimalno stvaranje kostiju | |
| JP2017079785A5 (enExample) | ||
| JP2015529225A5 (enExample) | ||
| JP2017507954A5 (enExample) | ||
| MA38406A1 (fr) | Virus de la maladie de newcastle et leurs utilisations | |
| SG148143A1 (en) | Antagonist anti-cd40 monoclonal antibodies and methods for their use | |
| JP2016538277A5 (enExample) | ||
| JP2016539125A5 (enExample) | ||
| RU2014111472A (ru) | Способ ингибирования клеточной активации, вызываемой инсулиноподобным фактором роста 1 | |
| EP4434540A3 (en) | Humanized anti-il-1r3 antibodies | |
| RU2011111391A (ru) | Способ лечения пациентов, страдающих рассеянным склерозом, антителами анти-il2r | |
| RU2014117510A (ru) | Лечение ревматоидного артрита | |
| JP2019528285A5 (enExample) | ||
| JP2018535961A5 (enExample) | ||
| EA201590726A1 (ru) | Лахинимод для уменьшения таламического поражения при рассеянном склерозе | |
| BR112014014824A2 (pt) | anticorpos antagonistas do receptor do hormônio de crescimento humano e métodos de uso dos mesmos | |
| JP2017520562A5 (enExample) | ||
| FI3359572T3 (fi) | Menetelmä multippeliskleroosin hoitamiseksi |